LMO4 Polyclonal Antibody

LMO4 encodes a cysteine-rich protein that contains two LIM domains but lacks a DNA-binding homeodomain. LIM domain transcription factor LMO4 may play a role as a transcriptional regulator or as an oncogene.

The LMO4 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of LMO4 protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and specificity towards the target protein.

The LMO4 Polyclonal Antibody exhibits exceptional performance in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence. It enables researchers to accurately quantify and visualize LMO4 protein expression in tissues and cells, facilitating comprehensive investigations into its biological functions and regulatory mechanisms.

With its superior sensitivity and low background noise, this antibody guarantees reliable and reproducible results, even in challenging experimental conditions. Its robust performance allows for the detection of low-abundance LMO4 protein levels, enabling researchers to explore its role in various physiological and pathological processes.

The LMO4 Polyclonal Antibody is manufactured under stringent quality control standards, ensuring batch-to-batch consistency and reliability. It is supplied as a ready-to-use solution, eliminating the need for time-consuming and error-prone antibody preparation steps.

In summary, the LMO4 Polyclonal Antibody is an indispensable tool for researchers studying LMO4 protein expression and its functional implications. Its exceptional sensitivity, specificity, and versatility make it an ideal choice for a wide range of applications in both basic and clinical research.